Please login to the form below

Welcoming analytics-driven digital marketing agency closerlook to the Fishawack Health pack

Fishawack Health enhances its omnichannel capabilities with the acquisition of closerlook, a data analytics and digital native healthcare agency specializing in intelligent omnichannel marketing solutions.

First row from left to right: David Ormesher, Jon Sawyer, Allison Davis

Second row: Ryan Mason, Dave Reidy, Steve Tulk

At Fishawack Health, we are always seeking opportunities to enhance our capabilities and help our life science clients navigate the new, dynamically changing healthcare environment.

As part of our commitment to our clients, their customers, and their patients, we intentionally seek out and acquire best-in-class agencies that can help us further our services. Our ambitious growth strategy plays a crucial role in helping us to achieve our mission of improving access and empowering healthcare professionals and patients with the knowledge needed to save lives.

Today, our clients are looking for bold collaboration and digital, data-driven, solutions that meet patient and healthcare professional needs in a new world. And that’s why we are excited to welcome Chicago-based closerlook LLC to our pack.

Meet closerlook

closerlook is a digital-native healthcare agency that leverages artificial intelligence (AI) and data analytics to develop omnichannel strategies, creative, and digital media solutions for life science brands across the entire pre-commercial and commercial lifecycle of a drug.

closerlook’s skills and software products in data science, AI, and advanced analytics provide life science brands with real-time insights and the ability to develop hyper-targeted and precisely personalized campaigns at scale.

When combined with Fishawack Health’s existing omnichannel services, which span medical communications, commercial, and consulting capabilities, life science companies will have the opportunity to access and benefit from an unrivaled offering that will help them precisely understand and engage stakeholders.

The firm’s approach to data-driven healthcare marketing is powered by its four capabilities: omnichannel strategy, conceptual creative and content, digital tactics and media management, and advanced analytics, each of which is informed by Backstage® Intelligence, the firm’s proprietary data and intelligence marketing hub.

The platform uses AI and data science to inform and precisely tailor healthcare professional and patient experiences, providing healthcare marketers with unrivaled access to an integrated platform, designed for competitive advantage.

Biopharma companies can use these insights to engage with customers and patients in novel and intelligent ways, driving innovation and connecting healthcare professionals and patients with the knowledge they need to improve health outcomes and live better lives.

The company works with a range of innovative biopharma companies including UCB, Novo Nordisk, Astellas, Akebia, TerSera Therapeutics, Zogenix, BioMarin, and argenx. Its clients benefit from the team’s deep expertise in specialty, oncology, and rare disease therapy areas, as well as in autoimmune and renal diseases, endocrinology, and rheumatology. closerlook’s experiences complement our broad healthcare expertise derived from partnering with all of the top 20 pharma companies, supporting 30 rare disease products across our client roster, and successfully launching 100+ new products, supported by150+ PhDs engaged full-time on the team.

In 2021 alone, closerlook has been nominated for several awards including Winner, Unbranded: Pharma at the Brand Film Awards, co-hosted by MM+M; Finalist, Best Launch Campaign at the MedAd News Manny Awards; and Finalist, Agency of the Year, Category II at the MedAd News Manny Awards, an accolade which complements Fishawack Health’s nomination for Network of the Year.

What the leaders said:

Oliver Dennis, Fishawack Health co-founder and CEO, said: “Traditionally, the healthcare sector has fallen behind when it comes to leveraging the power of innovative technologies and data to enhance commercial and medical communications strategies. The COVID-19 pandemic has highlighted the necessity of digital communication and the opportunities an omnichannel approach brings. Life science brands need a new breed of partner that offers bespoke teams who bring with them digital and analytics prowess, a rigorous understanding of the science, and the ability to develop impactful strategies and creative solutions.”

“closerlook’s advanced AI and analytics offering can track and optimize performance, delivering increased business results for clients. Through this combination of expertise, we can develop highly intelligent solutions that are integral for developing, launching and growing brands and portfolios in a complex and crowded marketplace.”

David Ormesher, CEO of closerlook, reveals: “We are energized by the prospect of joining a global team with the breadth and depth of Fishawack Health. I believe that the combination of our AI/advanced analytics-enabled omnichannel strategy, creative, and digital media with Fishawack Health’s global consulting, commercial and medical communications capabilities will create a unique commercialization offering for life science brands and healthcare companies looking for growth.

“We have spent over six months getting to know the Fishawack Health leadership, and we are excited about the alignment of vision, purpose, and culture between our two organizations. Over the past year, closerlook has experienced the fastest growth in its history and we expect Fishawack Health to supercharge that even more. We are looking forward to working together to achieve our mission of better health outcomes for patients and greater business results for the biopharma brands that serve them”.

Fishawack Health Group President Gail Flockhart said: “We are delighted to welcome closerlook to Fishawack Health, including their impressive and experienced management team who will no doubt play an important role in helping us further enhance our capabilities and services across the group.”

To find out more about our digital expertise, contact

Want to learn more about digital health trends? Download Delta magazine

8th June 2021



Company Details

Fishawack Health

+44 20 3328 1840

Contact Website

No. 3 Booths Park
Booths Hall
Chelford Road
WA16 8GS
United Kingdom

Latest content on this profile

Fishawack Health welcomes Mario Muredda as its new President of Marketing
Fishawack Health (FH) ushers in a new era of data-driven omnichannel marketing with the hire of healthcare marketing veteran Mario Muredda.
Fishawack Health
5 ways we’re enhancing our services to support our clients in 2023
Fishawack Health CEO Jon Koch explains the new platforms, tools, and services we’re elevating to drive innovation for our clients in 2023.
Fishawack Health
Why it’s time to apply a payer lens to your early pipeline planning
Value, evidence, and market access experts Jan McKendrick and Andrea Hamlin reveal why applying a payer lens early in the value assessment of pipeline assets is essential for driving commercial success.
Fishawack Health
The fast-paced future of cell and gene therapies
In this report, we interview patients, researchers, and biopharmaceutical leaders to explore the complex landscape for the development of cell and gene therapies and share commercial recommendations from our specialist teams.
Fishawack Health
Omnichannel scientific engagement and the use of archetypes to drive personalization
Natasha Cowan, Senior Corporate Communications Manager, explores with Gary Lyons, Head of Strategy, his recent plenary session at the 18th Annual ISMPP conference that focused on how scientific communicators can use archetypes to segment their audience and develop personalized learning journeys for healthcare professionals.
Fishawack Health
The promised land of gene therapy: Commercialization of novel gene-editing technology in beta-thalassemia
With transformative treatments that leverage CRISPR technology, there are many challenges to overcome throughout the journey of development through to patient access. We interviewed a researcher at a top 20 pharma company, multiple patients, and our own market access experts for their insights into the process, obstacles, and opportunities for biopharmaceutical companies to meet patient needs and achieve success in the market.
Fishawack Health